In-vitro Diagnostics

Format: 2016-12-04
Format: 2016-12-04
December 01, 2016 | 79 Pages | SKU: IRTNTR10992

Outlook of the global nucleic acid testing market

The global market for nucleic acid testing will grow at a CAGR of nearly 10% by 2020. According to the analysts, eminent factors like the higher adoption rate of molecular point-of-care (POC) testing will aid in the strong growth of this market during the forecast period. POC testing provides immediate results in non-laboratory settings to support more patient-centered approaches to healthcare delivery. The sensory technology enables the rapid analysis of blood samples. In the molecular diagnosis field, there is a higher adoption for POC testing systems as it helps in glucose self-testing. Also, due to the high cost of clinical diagnostic devices, the preference for molecular POC testing has increased.

In terms of geography, the nucleic acid testing market will witness rapid growth in the Americas. The market in this region is dynamic, with the presence of more than 20 established companies that compete for the sales of nucleic acid testing systems and reagents. The market in this region also provides significant opportunities for vendors, particularly in the US, as private and government research institutes and pharmaceutical companies are extensively adopting genome engineering, next-generation sequencing and gene editing technologies.

Competitive landscape and key vendors

The global nucleic acid market is in nascent stage and is characterized by the presence of large (tier 1), medium (tier 2) and small sized companies (tier 3) companies. Most of the top tier companies are present in the Americas and Western Europe. However, in APAC (such as China) there are many local vendors that account for a major share of the market in some areas. Factors such as advances in technology and new product launches also help in increasing the level of competition among vendors.

Top vendors in this market are -

November 29, 2016 | 91 Pages | SKU: IRTNTR10968

Global outlook of the prostate cancer drugs market

Technavio’s market research analysts predict the global prostate cancer drugs market to grow steadily during the predicted period and post an impressive revenue of more than USD 10 billion by 2020. This industry research report identifies the preference of physicians towards the adoption of hormonal therapies to be one of the major factors that will have a positive impact on the growth of the drugs market for the treatment of prostate cancer. Hormonal therapies stop the growth of cancer cells by reducing the amount of testosterone in the body. Due to their effectiveness, hormonal therapies have an increased adoption among physicians. This increased preference will improve the sales of hormonal therapies including luteinising hormone blockers, GnRH blockers, anti-androgens, and abiraterone and will, in turn, propel the market’s growth prospects.

One of the major trends that will gain traction in this market is the advances in early stage diagnosis through new diagnostic methods. The emergence of novel diagnostic tests that will be more accurate than the conventional prostate-specific antigen (PSA) test will help scientists diagnose prostate cancer much better. New tests such as phi test, 4Kscore test, Progensa, TMPRSS2: ERG and ConfirmMDX will be more accurate in early stage diagnosis. This in turn, will enhance the patient pool and consecutively aid in the growth of the market.

Competitive landscape and key vendors

The market is characterized by the presence

Overview of the global hospital-acquired urinary tract infection testing market

Technavio’s market research analyst predicts the global hospital-acquired urinary tract infection testing market to grow at a CAGR of around 19% between 2016 and 2020. Urinary tract infection occupies the largest share in the HAIs category, and the number is constantly growing. This has encouraged several vendors to develop innovative testing products that will subsequently augment the demand for hospital-acquired urinary tract infection testing products. Several technological advancements have enhanced the testing procedures for urinary tract infection, as they are more precise, sensitive, generate faster outcomes, and provide a broader range of pathogen detection as compared with the most traditional methods. Moreover, the innovative techniques in bioinformatics and software programs help manage a massive amount of data and offer better-quality results from tests such as molecular diagnostics. These methods provide initiation of infection control practices, optimization of treatment selection, reduced hospital stay, and improved surveillance of infectious diseases. Also, hospitals are setting up infection control committees that focus on only HAIs. Such infection control committee is responsible for the evaluation and planning of evidence-based practice, resource allocation, and prioritization of matters related to infection control.

Geographically, the Americas dominated the market and accounted for the largest market share in 2015. The high prevalence of infectious diseases, leading to the increased demand for diagnostic products and services and focus on disease management has propelled market growth in this region. The US is the largest revenue contributor for the hospital-acquired UTI testing market in the Americas owing to the massive sales of

November 14, 2016 | 101 Pages | SKU: IRTNTR10792

Overview of the global in-vitro diagnostics instruments market

The global in-vitro diagnostics (IVD) instruments market is anticipated to grow at a steady rate and will post a CAGR of close to 10% during the forecast period. The increasing demand for personalized medicine is driving the growth prospects of the market during the forecast period. Personalized medicines can be developed by the identification of a defective protein and gene structure of the patient. For instance, tests developed by Roche Diagnostics and Qiagen can identify defective proteins and genes extracted from tissues and develop advanced companion diagnostics to target individuals that respond to specific treatments. Also, the demand for personalized medicines is increasing in the oncology therapeutic area because it facilitates better patient management and enables individualized treatment through diagnostic tests for real-time and rapid results. Furthermore, this growing demand encourages many leading pharmaceutical companies to develop personalized medicine and offer incentives for cancer therapies. Moreover, one of the advantages of developing personalized treatment is that it enables better channeling of patient diagnostic information and communication of results to clinicians.

In terms of geography, the Americas accounted for the maximum market share and is expected to dominate the market during the next four years. Factors such as the changing lifestyle, increased alcohol consumption, smoking, and unhealthy food habits are driving the need for personalized treatment among patients in the region. Also, advancements in new technology and subsequent product launches will drive the growth prospects for the market in the Americas.

Competitive landscape and key vendors

November 11, 2016 | 73 Pages | SKU: IRTNTR10773

Global overview of the home-care monitoring and diagnostics market

Technavio’s market research analysts have predicted that the global market for home-care monitoring and diagnostics will witness fast-paced growth and post a CAGR of close to 9% during the forecast period. The rising disposable income level and recent improvements in living standards are some of the major factors driving this market’s growth. Most people in developed and developing countries are now able to use self-care medical devices owing to their increased disposable income. Over the past decade, the disposable income of more than 40% of people in North America and about 30% in Europe has increased. Also, the disposable income of people in APAC has also increased significantly, leading to high customer expenditure and changes in consumption patterns of self-care medical devices. End-users are ready to pay premium prices for branded sports equipment and pedometers for factors such as comfort, quality, and efficiency.

One of the recent trends spurring the growth prospects for this market is the increasing focus on online promotion and marketing strategies. The majority of vendors are adopting various online marketing and promotional strategies to provide better accessibility of their products to end users, which is, in turn, driving product sales. Moreover, these strategies help vendors minimize setup, distribution, and operational costs. Many large and small vendors are selling vital signs monitors online as they are of greater convenience for consumers. 

Competitive landscape and key vendors

The global home-care monitoring and diagnostics

November 09, 2016 | 82 Pages | SKU: IRTNTR10736

Overview of the blood stream infection testing market

Extensive research carried out by the analysts at Technavio has shown that the global blood stream infection testing market is anticipated to witness impressive growth and will post a staggering CAGR of close to 8% during the forecast period. The increasing adoption of patient-centered healthcare by digital technology is one of the major factors driving this market’s growth. Electronic health records are maintained by telehealth, personal health records, and team care, by providing clinical health support for chronic diseases. As a result, people suffering from chronic conditions, such as HIV, can use personal health records to manage and monitor the effect of the treatment regimen. This recent increase in the dependence on digital technology across the healthcare sector will contribute to the growth of the blood stream infection testing market over the next four years.

In terms of geographical regions, the Americas was the highest revenue contributing region during 2015 and will lead the market over the next four years. In countries like the US and Canada, there is an increased awareness of blood safety and transfusion-transmitted infections. Since the need for blood transfusion is high in these countries, the demand for blood donation is also high. Moreover, with the growing prevalence of blood diseases in the US, the demand for blood diagnostic products and services in this region is also increasing.

Competitive landscape and key vendors

The global blood stream